Aperture Sectors › Healthcare & Life Sciences › Clinical decision support
Clinical decision support funding
Clinical decision support
A sub-sector of Healthcare & Life Sciences. Each company counts once, in its main sub-sector.
79 rounds, $1.9B raised by 71 companies, Jan 2, 2023 to Nov 14, 2026, 4% of Healthcare & Life Sciences capital. Top three companies: OpenEvidence 39%, Persivia 6%, Neo Medical 4%.
| Company | HQ | Capital raised | Rounds | Exit |
|---|---|---|---|---|
| OpenEvidence | United States | $735M | 4 | — |
| Persivia | United States | $107M | 1 | — |
| Neo Medical | Switzerland | $81M | 1 | — |
| Caresyntax | United States | $80M | 1 | — |
| Regard | United States | $61M | 1 | — |
| Akido Labs | United States | $60M | 1 | — |
| FIZE Medical | Israel | $50M | 2 | — |
| xCures | United States | $46M | 1 | — |
| AITRICS | South Korea | $44M | 2 | — |
| Volta Medical | France | $38M | 1 | — |
| Healthleap | United States | $38M | 1 | — |
| Glytec | United States | $36M | 1 | — |
| Health Data Analytics Institute | United States | $31M | 1 | — |
| Vera Health | United States | $28M | 1 | — |
| deepc | Germany | $26M | 2 | — |
| Clinomic | Germany | $25M | 1 | — |
| Layer Health | United States | $25M | 2 | — |
| Penguin Ai | United States | $25M | 1 | — |
| Ataraxis AI | United States | $20M | 1 | — |
| Blossom Health | United States | $20M | 1 | — |
| Method AI | United States | $20M | 1 | — |
| MDI Health | Israel | $20M | 1 | — |
| Onos Health | United States | $17M | 1 | — |
| Karoo Health | United States | $16M | 1 | — |
| Ferrum Health | United States | $16M | 1 | — |
| Company | Amount | Stage | Announced |
|---|---|---|---|
| OpenEvidence | $250M | Series D | Jan 21, 2026 |
| OpenEvidence | $210M | Series B | Jul 15, 2025 |
| OpenEvidence | $200M | Series C | Oct 20, 2025 |
| Persivia | $107M | Unlabeled | Apr 30, 2025 |
| Neo Medical | $81M | Series B | Sep 17, 2024 |
| Caresyntax | $80M | Series C | Aug 15, 2024 |
| OpenEvidence | $75M | Series A | Feb 19, 2025 |
| Regard | $61M | Series B | Jul 11, 2024 |
| Akido Labs | $60M | Series B | May 15, 2025 |
| xCures | $46M | Series B | Jun 24, 2026 |